Relay Therapeutics RLAY
NASDAQ RLAY
$19.04 +0.03 (+0.16%)
As of: Sep 4, 2026 · 3:59 PM EDT

Relay Therapeutics (RLAY) Price to Earnings (2020 - 2026)

Analysis

Relay Therapeutics (RLAY) Price to Earnings (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Relay Therapeutics 3.87 Bn 3.87 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -48.84
Mar 31, 2026 -25.69
Dec 31, 2025 -26.78
Sep 30, 2025 -12.18
Jun 30, 2025 -8.52
Mar 31, 2025 -5.80
Dec 31, 2024 -9.09
Sep 30, 2024 -13.41
Jun 30, 2024 -9.43
Mar 31, 2024 -13.49
Dec 31, 2023 -16.81
Sep 30, 2023 -15.76
Jun 30, 2023 -15.55
Mar 31, 2023 -21.23
Dec 31, 2022 -25.89
Sep 30, 2022 -32.10
Jun 30, 2022 -22.64
Mar 31, 2022 -45.79
Dec 31, 2021 -49.26
Sep 30, 2021 -48.10